{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:49:58Z","timestamp":1769849398721,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"DOI":"10.7759\/cureus.102655","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:51:20Z","timestamp":1769795480000},"source":"Crossref","is-referenced-by-count":0,"title":["Combined Oral Contraceptive Pills Versus Progestin-Only Pills for Heavy Menstrual Bleeding: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Gehad S","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebtihag M","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhila","family":"Karamalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuhama I","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsa Mohamed","family":"Hamid Musa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozaz K","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suheir I","family":"Elshaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Muddassar","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000154.pub3","article-title":"Combined hormonal contraceptives for heavy menstrual bleeding","volume":"2","author":"Lethaby A","year":"2019","unstructured":"Lethaby A, Wise MR, Weterings MA, Bofill Rodriguez M, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019, 2:CD000154. 10.1002\/14651858.CD000154.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(17)30072-5","article-title":"Heavy menstrual bleeding: an update on management","volume":"151 Suppl 1","author":"Davies J","year":"2017","unstructured":"Davies J, Kadir RA. Heavy menstrual bleeding: an update on management. Thromb Res. 2017, 151 Suppl 1:S70-7. 10.1016\/S0049-3848(17)30072-5","journal-title":"Thromb Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14913","article-title":"Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review","volume":"99","author":"Forslund M","year":"2023","unstructured":"Forslund M, Melin J, Alesi S, et al.. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review. Clin Endocrinol (Oxf). 2023, 99:79-91. 10.1111\/cen.14913","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2024.2317295","article-title":"Health benefits of combined oral contraceptives - a narrative review","volume":"29","author":"Coelingh Bennink HJ","year":"2024","unstructured":"Coelingh Bennink HJ, van Gennip FA, Gerrits MG, Egberts JF, Gemzell-Danielsson K, Kopp-Kallner H. Health benefits of combined oral contraceptives - a narrative review. Eur J Contracept Reprod Health Care. 2024, 29:40-52. 10.1080\/13625187.2024.2317295","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000591","article-title":"Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices","volume":"2024","author":"Skeith L","year":"2024","unstructured":"Skeith L, Bates SM. Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices. Hematology Am Soc Hematol Educ Program. 2024, 2024:644-51. 10.1182\/hematology.2024000591","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40834-020-00142-5","article-title":"The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control","volume":"6","author":"Shoupe D","year":"2021","unstructured":"Shoupe D. The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control. Contracept Reprod Med. 2021, 6:3. 10.1186\/s40834-020-00142-5","journal-title":"Contracept Reprod Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper NK","year":"2016","unstructured":"Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM. Progestin-only contraception and thromboembolism: a systematic review. Contraception. 2016, 94:678-700. 10.1016\/j.contraception.2016.04.014","journal-title":"Contraception"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/OAJC.S7943","article-title":"Treatment of heavy menstrual bleeding with a new combination of estradiol valerate and dienogest","volume":"1","author":"Bahamondes L","year":"2010","unstructured":"Bahamondes L, Monteiro I, Fernandes A. Treatment of heavy menstrual bleeding with a new combination of estradiol valerate and dienogest. Open Access J Contracept. 2010, 1:119-26. 10.2147\/OAJC.S7943","journal-title":"Open Access J Contracept"},{"key":"ref9","unstructured":"RoB 2. A revised Cochrane risk-of-bias tool for randomized trials. (2019). Accessed: December 5, 2025: https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/9781119756194.ch8","article-title":"Assessing risk of bias and applicability","author":"Reitsma JB","year":"2023","unstructured":"Reitsma JB, Rutjes AR, Whiting P, Yang B, Leeflang MM, Bossuyt PM, Deeks JJ. Assessing risk of bias and applicability. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy\r\n. Deeks JJ, Bossuyt PM, Leeflang MM, Takwoingi Y (ed): Wiley, Hoboken, NJ; 2023. 10.1002\/9781119756194.ch8"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2005.06.068","article-title":"The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days","volume":"73","author":"Foidart JM","year":"2006","unstructured":"Foidart JM, Sulak PJ, Schellschmidt I, Zimmermann D. The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days. Contraception. 2006, 73:34-40. 10.1016\/j.contraception.2005.06.068","journal-title":"Contraception"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0724","article-title":"Long-term progestin-only contraceptives result in reduced endometrial blood flow and oxidative stress","volume":"91","author":"Hickey M","year":"2006","unstructured":"Hickey M, Krikun G, Kodaman P, Schatz F, Carati C, Lockwood CJ. Long-term progestin-only contraceptives result in reduced endometrial blood flow and oxidative stress. J Clin Endocrinol Metab. 2006, 91:3633-8. 10.1210\/jc.2006-0724","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05340-4","article-title":"A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4\u00a0mg over nine cycles in comparison with desogestrel 0.075\u00a0mg","volume":"300","author":"Palacios S","year":"2019","unstructured":"Palacios S, Colli E, Regidor PA. A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4\u00a0mg over nine cycles in comparison with desogestrel 0.075\u00a0mg. Arch Gynecol Obstet. 2019, 300:1805-12. 10.1007\/s00404-019-05340-4","journal-title":"Arch Gynecol Obstet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20200901","article-title":"A randomized controlled trial to study the efficacy of intravaginal hormonal ring for control of heavy menstrual bleeding as compared to combined oral contraceptive pills","volume":"9","author":"Saha T","year":"2020","unstructured":"Saha T, Bharadwaj MK, Vardhan SJ. A randomized controlled trial to study the efficacy of intravaginal hormonal ring for control of heavy menstrual bleeding as compared to combined oral contraceptive pills. Int J Reprod Contracept Obstet Gynecol. 2020, 9:1205-13. 10.18203\/2320-1770.ijrcog20200901","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jog.16340","article-title":"Efficacy and safety of drospirenone as a progestin-only pill in Japanese women: a phase III study","volume":"51","author":"Kitamura K","year":"2025","unstructured":"Kitamura K, Colli E, Kikuyama R, Kurihara Y, Azuma R, Kagawa T. Efficacy and safety of drospirenone as a progestin-only pill in Japanese women: a phase III study. J Obstet Gynaecol Res. 2025, 51:e16340. 10.1111\/jog.16340","journal-title":"J Obstet Gynaecol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5455\/2319-2003.ijbcp003512","article-title":"Comparison of the efficacy and safety of norethisterone vs combined oral contraceptive pills for the management of puberty menorrhagia","volume":"1","author":"Patel NK","year":"2012","unstructured":"Patel NK, Patel S, Damor R, et al.. Comparison of the efficacy and safety of norethisterone vs combined oral contraceptive pills for the management of puberty menorrhagia. Int J Basic Clin Pharmacol. 2012, 1:191-5. 10.5455\/2319-2003.ijbcp003512","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref17","article-title":"Comparative study of the effects of the use of combined oral pills and progestin-only pills in Nigerian females","volume":"2","author":"Ajugwo AO","year":"2014","unstructured":"Ajugwo AO, Adias TC, Erhabor TA, et al.. Comparative study of the effects of the use of combined oral pills and progestin-only pills in Nigerian females. Am J Biol Life Sci. 2014, 2:80-3.","journal-title":"Am J Biol Life Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-019-0766-6","article-title":"Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial","volume":"19","author":"Dean J","year":"2019","unstructured":"Dean J, Kramer KJ, Akbary F, Wade S, H\u00fcttemann M, Berman JM, Recanati MA. Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial. BMC Womens Health. 2019, 19:70. 10.1186\/s12905-019-0766-6","journal-title":"BMC Womens Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/cjhr.cjhr_92_18","article-title":"A comparative study of norethisterone and combined oral contraceptive pill in the treatment of dysfunctional uterine bleeding","volume":"6","author":"Sen S","year":"2019","unstructured":"Sen S, Mandal TK, Dutta A, et al.. A comparative study of norethisterone and combined oral contraceptive pill in the treatment of dysfunctional uterine bleeding. 2019, 6:87-92. 10.4103\/cjhr.cjhr_92_18"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20175844","article-title":"Comparing combined pills to progesterone-only pills for abnormal uterine bleeding in perimenopausal women","volume":"15","author":"Sahasikdar S","year":"2023","unstructured":"Sahasikdar S, Roy S, Rahaman Kazi R, et al.. Comparing combined pills to progesterone-only pills for abnormal uterine bleeding in perimenopausal women. Int J Pharm Clin Res. 2023, 15:10.18203\/2320-1770.ijrcog20175844","journal-title":"Int J Pharm Clin Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154634","article-title":"Bleeding patterns of oral contraceptives with a cyclic dosing regimen: an overview","volume":"11","author":"Archer DF","year":"2022","unstructured":"Archer DF, Mansour D, Foidart JM. Bleeding patterns of oral contraceptives with a cyclic dosing regimen: an overview. J Clin Med. 2022, 11:4634. 10.3390\/jcm11154634","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.958","article-title":"An update on contraception in polycystic ovary syndrome","volume":"36","author":"Oguz SH","year":"2021","unstructured":"Oguz SH, Yildiz BO. An update on contraception in polycystic ovary syndrome. Endocrinol Metab (Seoul). 2021, 36:296-311. 10.3803\/EnM.2021.958","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/442686-combined-oral-contraceptive-pills-versus-progestin-only-pills-for-heavy-menstrual-bleeding-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:51:21Z","timestamp":1769795481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/442686-combined-oral-contraceptive-pills-versus-progestin-only-pills-for-heavy-menstrual-bleeding-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.102655","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}